Cancer researchers have been working on coming up with better ways to detect and treat cancer for years. Now, thanks to the work of inventor and cell biologist Dr. Andrew Conrad, the combination of nanotechnology and Google technology has the potential to find and destroy cancer cells in the near future.
Biology Meets Technology
In the latest cancer news, tech giant Google announced a new patent for a wearable device that can detect cancer cells and potentially get rid of them. The device is designed to be worn on the wrist and works with a pill containing magnetic nanoparticles. The device projects a magnetic field that draws the nanoparticles and any cells that are targeted, such as cancerous cells. The nanoparticles are meant to latch onto the targeted cells and draw them toward the device, which then creates and sends energy to blood vessels. Theoretically, this process would result in the cancerous cells being changed into harmless ones or destroyed altogether.
Worth the Wait
Google’s wearable device is still pending approval by the FDA and isn’t expected to be out for five years or more, but it could eventually give hope to those who are either at risk of cancer or those who want an alternative, non-toxic way to treat cancer. The device would provide a convenient and non-invasive way to fight cancer. It could also end up being used to target harmful abnormal cells associated with several other diseases, including Parkinson’s disease and HIV.
If you would like more information on non-toxic forms of treatment for cancer, please contact Issels®. We offer a wide range of Integrative Immunotherapy Programs, as well as cancer vaccines.
Vaccines save lives by utilizing the patient’s immune system to attack harmful cells. Much like flu vaccines prepare the person’s body to defend against pathogens, cancer prevention vaccines are given to people who do not have cancer to help their body identify and destroy infections known to lead to cancer. Treatment vaccines are for people who are already diagnosed with cancer. Issels® Integrative Immuno-Oncology uses non-toxic vaccine and cell therapy that is prepared from the patient’s own blood.
Washington University study
A recent study by scientists at Washington University found personalized cancer treatment was able to cure 90 percent of the mice used in the study that had advanced muscle cancer. This success prompted Alumni Professor of Pathology and Immunology for the university Robert Schreiber, PhD, who was senior author of the study, to say personalized cancer vaccines should be used to treat cancer in humans right away.
Years of research on cancer genetics and how the immune system interacts with cancer have made new vaccines and treatments possible. Scientists agree immunotherapy is the best path to a cancer cure.
A personalized vaccine requires samples from the DNA of the individual’s tumor and healthy tissue. This aspect of creating an effective vaccine is difficult because cancer cells develop from the healthy cells of the person and are not easily recognized as harmful by the immune system. Despite the difficulties, experts agree that this type of integrative strategy is the best path to successfully treating cancer.
To find out more about the cutting edge non-toxic treatments and cell therapies utilized by Issels® Integrative Immuno-Oncology, contact us by phone or via our short online form.
It might seem like it’s too good to be true, but what Google is doing is far from science fiction. They’re working on developing a nano-pill that can detect cancer, as well as other diseases and illnesses. The nano-pill is still being worked on, but the folks at Google are confident that they have the knowledge and capability they need to make their newest idea a reality.
How does it work?
The nano-pill works by releasing nano particles into the body that are drawn to cancer cells like a magnet. The particles latch on and any information that’s gathered about the cancer cells is sent to a sensor. The best part is that people can begin to get treatments before they would normally have them under traditional detection methods.
According to a recent article on Wired.com, it’s relatively easy for academic researchers to pinpoint what might work best for such a project, but it takes a team of qualified engineers, scientists and technicians to design the hardware for such a product. That’s where Google comes in, and they’ve brought their best team members to the table.
Of course, the challenge is going to be in the clinical trials. Some trials have begun on artificial human limbs, but there is still much research to be done before the nano pill is ready to take the next step. It might be a few years before it hits the market.
Non-traditional cancer treatments are what we specialize in, here at Issels®. If you’ve been looking for alternative cancer treatments for yourself or a loved one, please contact us. We would love to talk with you about our options.
After decades without major developments, the study of advanced bladder cancer has reached a new breakthrough thanks to an alternative cancer treatment.
An immunotherapy medicine has been found by researchers to shrink or eliminate tumors. Patients who have not responded positively to chemotherapy and other standard therapies have improved or entered remission, based on the initial findings.
The immunotherapy has been awarded “Breakthrough Therapy Designation” by the U.S. Food and Drug Administration. This means the FDA will expedite the review process to help patients with the serious disease receive the treatment as quickly as possible.
Promising Evidence for Bladder Cancer Immunotherapy
In a British trial, advanced bladder cancer patients received a new medication developed by the Swiss lab Roche.
Patients carrying the PD-L1 protein responded best to the treatment. The results:
Tumors shrank in 43 percent of patients within 6 weeks of immunotherapy
After 12 weeks, 52 percent had shrunken tumors
2 out of 30 patients had no signs of cancer following the treatment
Among PD-L1 negative patients, 11 percent saw a reduction in tumor size.
While this particular cancer immunotherapy awaits full FDA approval, the signs are encouraging. Only common side effects of cancer treatments were reported, including loss of appetite and tiredness.
Bladder cancer has long been considered one of the most difficult forms of cancer. This breakthrough provides an alternative to chemotherapy, which has for years been the only treatment option for advanced cases.
Issels® champions alternative cancer treatments, including many immunotherapies that are considered breakthroughs. Get in touch with us to discuss the latest cancer treatment options we provide.
The growing number of immunotherapy success stories has given new hope to cancer patients, and their families.
Our Issels®treatment centers have comprehensive immunotherapy programs that have remarkable results.
According to an article on WebMD, this non-toxic cancer treatment could be a pathway to a cure. It worked for Milton Wright III, who according to the article, had leukemia since he was 8 years-old. After years of treatment his doctors thought the cancer was gone.
Unfortunately, it came back for a third time when he was twenty years-old. He ended up taking part in CAR T-cell therapy trail, which is a type of immunotherapy. This type of treatment super-charged the immune system via genetically modified cells that both recognized, and attacked the cancer cells. In less than a month, CAR T-cell therapy got rid of Wright’s cancer.
That is just one of many immunotherapy success stories. Our own Issels® treatment program has many success stories that will bring new hope to any cancer patient.
About CAR T-cell therapy:
Over 100 trial patients have tried this treatment since 2009. Over 70 of those patients went into complete remission. This type of cancer treatment was used with patients who have certain blood cancers such as myeloma, and leukemia. Early research is showing that one day it could be used for more common tumors.
CAR T-cell therapy, like all types of immunotherapy, offers an improved quality of life during, and after the cancer treatment.
For more information about immunotherapy, please contact us at Issels® via our website. We have experienced, qualified, and compassionate doctors who specialize in immunotherapy cancer treatment.
Google Ventures has recently made a large investment into Flatiron Health Inc., a medical software company whose cancer patient data is used to help doctors make cancer treatment decisions. The $100-plus million investment reportedly enabled the company to purchase another software firm, Altos Solutions, which compiles oncology data and whose electronic medical records are cloud-based.
A plethora of alternative cancer treatment information – soon to be accessible via the cloud.
Flatiron’s software compiles a wide array of data, including clinical and genomic data, information on patient outcomes, notes from doctors, billing, and more for the use of oncologists. Compiled with Altos’ treatment data and cloud accessibility, this information will give doctors wider access to clinical trial information including past cancer treatments and outcomes which would have otherwise been difficult to access.
An investment in hope…
Bill Maris, managing partner with Google Ventures, stated they typically don’t make investments of this size unless they really believe in the team, the product, and the good it can do for the world. The acquisition of Altos by Flatiron is very complementary, offering a significant step forward in cancer care.
Google Ventures also investing in other medical data software companies.
Other Google Venture investments include DNAnexus, Inc., who is building the world’s first searchable archive of DNA information, as well as Foundation Medicine, with its tumor analyzing software, and Predilytics Inc., which tracks hospital discharges and re-admissions.
This combination of healthcare and internet technology offers an elegant solution for patient care, and with the help of Google Ventures, a clearer view of cancer patient needs and treatment options appears to be on the horizon.